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Background: Nasopharyngeal carcinoma (NPC) is known for its high incidence of neck lymph node metastasis,
which represents poor prognosis. The present study aimed to examine the anti-metastatic properties of Selaginella
tamariscina extract (STE) in human nasopharyngeal carcinoma HONE-1 cells in vitro.
Methods: Cell viability was examined by MTT assay, whereas cell motility was measured by invasive, migration and
would healing assays. Real-time PCR, and promoter assays confirmed the inhibitory effects of STE on matrix
metalloproteinase-9 (MMP-9) mRNA level in HONE-1 cells.
Results: The STE inhibits 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced HONE-1 cell migration and invasion
in a concentration-dependent manner. By zymographic and Western blot analyses, STE was shown to inhibit the
activities and expression of MMP-9. Treatment of STE on TPA-induced HONE-1 cells inhibited MMP-9 expression and
ERK1/2 phosphorylation without affecting JNK and p38 phosphorylation.
Conclusions: STE inhibits MMP-9 expression and HONE-1 cell metastasis. Its inhibitory effects may involve the Src/
FAK/ERK 1/2 pathway. STE may have the potential of being an anti-metastatic agent against NPC.
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Nasopharyngeal carcinoma (NPC) remains endemic
among ethnic Chinese and the Inuits of Alaska. It is a dis-
tinct entity of head and neck cancers because of its char-
acteristic epidemiology, pathogenesis, and association with
the Epstein-Barr virus [1]. Metastasis of cancer cells to the
neck lymph nodes, which can occur in up to 75% of NPC
patients, represents an adverse prognostic factor of the
disease [2]. Distant metastases, such as those to the lungs,
liver, and bone, remain a major cause of treatment failure
[3]. Metastasis is a phenomenon composed of multiple se-
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reproduction in any medium, provided the orincluding reduction of tumor cell adhesion, degradation of
extracellular matrix (ECM), enhancement of cell motility,
and promotion of neo-vascularization [4]. Thus, a degrad-
ation of the ECM and components of the basement mem-
brane caused by the concerted action of proteinases like
matrix metalloproteinases (MMPs), cathepsins, and plas-
minogen activators (PA) play an important role in tumor
invasion and metastasis [5,6]. Among these enzymes,
MMP-2 and MMP-9 can degrade most ECM components
and are profoundly involved in the development of cancer
invasion and metastasis [7,8]. Therefore, the inhibition of
MMP-2 or MMP-9-mediated migration or invasion may
be a preventive method of limiting cancer metastasis.
Selaginella tamariscina (Beauv.) is a traditional Chinese
herbal medicine for chronic trachitis. Its major constitu-
ents are flavonoids (e.g. amentoflavone, hinokiflavone,d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Hsin et al. BMC Complementary and Alternative Medicine 2013, 13:234 Page 2 of 11
http://www.biomedcentral.com/1472-6882/13/234d-glucose, dfructose and d-rhamnose) [9-11]. Previous
studies have demonstrated that Selaginella tamariscina
possesses anti-bacterial, anti-hypertensive, and anti-
hyperglycemic effects [10,12,13]. Moreover, Selaginella
tamariscina has been shown to have anti-tumor activities,
probably via an expression of the p53 tumor suppressor
gene and an induction of G1 arrest in the cell cycle against
certain tumor cell lines [14]. Recently, Yang et al. found
that Selaginella tamariscina extract (STE) can down-
regulate the expression of MMPs and u-PA, and inhibit
the invasion and metastatic activities of lung cancer cells
[15]. There is, however, no data about the anti-metastatic
potential of STE on NPC cancer cells. Thus, this study
examined the effects of aqueous extracts of Selaginella
tamariscina with potential anti-metastatic properties in
12-O-tetradecanoylphorbol-13-acetate (TPA)-treated hu-
man NPC HONE-1 cells in vitro to investigate the signal-
ing pathway of the process.
Methods
Preparation of Selaginella tamariscina extracts
Selaginella tamariscina (Beauv.) leaves were purchased
from herb stores in Taichung, Taiwan and the Selaginella
tamariscina extracts (STE) were prepared as described
previously [16]. The plant material was identified at the
Department of Biochemistry of Chung Shan Medical
University in Taichung and a voucher specimen is depos-
ited. Briefly, 100 g of air-dried leaves were boiled at 70°C
for 24 hours with 500 mL of 50% ethanol. The extraction
procedure was repeated twice. The solvent was removed
from the combined extract using a vacuum rotary evapor-
ator. The filtrate was then lyophilized and stored at −20°C
until further studies were to be conducted. A voucher spe-
cimen was deposited in the National Research Institute of
Chinese Medicine, Taiwan [16].
The extraction yield was 2.8% (w/w) and the chemical
profile of STE was analyzed using high-pressure liquid
chromatograms (HPLC)-mass spectrometer. Briefly, the
STE was analyzed by Hitachi L-6200 with an L-4500
Diode Array detector with a PE Sciex Qstar Pulsar
ESI-TOF mass spectrometer. Samples (10 μl) were
injected onto a Merck LiChrospher 100 RP-18 column
(4mm×250 mm). The column was equilibrated in 0.05%
acetic acid/water (solution A) and elution of the compo-
nents was achieved by increasing the concentration of
solution B (100% acetonitrile) from 0 to 100% in 30 min
at a flow rate of 1 ml/min. Absorbance was monitored at
254 nm. The molecular masses of the peaks were deter-
mined from electro-spray ionization mass spectra using
a multiply-charged ion profile based on the modified
method of Chang et al. [17]. For subsequent experi-
ments, the STE powder was dissolved in dimethyl sulfate
(DMSO) to achieve designed concentrations (0, 25, 50,
75, and 100 μg/mL).Cell and cell culture
A human nasopharyngeal carcinoma cell line from ATCC
(Manassas, VA), HONE-1 cells, was cultured in RPMI-
1640 medium (Life Technologies, Grand Island, NY), 10%
fetal bovine serum, 2 mM glutamine, 100 U/ml penicillin,
and 100 μg/ml streptomycin. All cell cultures were
maintained at 37°C in a humidified atmosphere of 5%
CO2. For STE treatment, appropriate amounts of stock
solution of STE were added into the culture medium to
achieve the indicated concentrations. The cells were then
incubated for the indicated time periods. Dimethyl sulfox-
ide solution without STE was used as blank reagent.
Analysis of cell viability (MTT assay)
To evaluate the cytotoxicity of STE, an MTT colorimet-
ric assay was performed to determine cell viability [18].
Cells were seeded in 24-well plates at a density of 1×105
cells per well and treated with 0, 25, 50, 75, 100, 150 and
200 μg/mL of STE at 37°C in 5% CO2 for 24 h and 48 h.
At the end of the exposure period, the cells were washed
with PBS and incubated with 0.8 mL of MTT (Sigma
chemical Co., St. Louis, MO, USA) per well (final con-
centration, 0.5 mg/mL) at 37°C in 5% CO2 for 4 h. The
viable cell number was directly proportional to the pro-
duction of formazan following solubilization with iso-
propanol, which was measured spectrophotometrically
at 563 nm (Beckman Spectrophotometer DU640, Beckman
Instruments, Fullerton, CA, USA).
Cell migration and invasion assays
Cell migration and invasion were assayed according to the
methods described by Chu et al. [19]. After treatment with
STE for 24 h, the surviving HONE-1 cells were harvested
and seeded to a Boyden chamber (Neuro Probe, Cabin
John, MD, USA) at 104 cells per well in serum-free
medium, and then incubated for 24 h at 37°C. To deter-
mine cell migration, the cells were seeded into the Boyden
chamber on membrane filters that were not coated with
Matrigel. The filters were then air-dried for 5 h in a lam-
inar flow hood. The migrating cells were fixed with
methanol and stained with Giemsa. The cell numbers
were counted by light microscopy.
For the invasion assay, 10 μL Matrigel (25 mg/50 mL;
BD Biosciences, MA, USA) was applied to 8 μm pore
size polycarbonate membrane filters. The bottom cham-
ber contained standard medium. The invasion of cells
treated or untreated with STE was measured as in the
migration assay.
Determination of MMP-9 activity by zymography
The activities of MMP-9 in the conditional medium were
measured by gelatin zymography protease assays as previ-
ously described [20]. Briefly, collected media of an appro-
priate volume were prepared with SDS sample buffer
Table 1 Primers list for real-time PCR assay
Primers used in real-time
PCR
Sequence (5’ to 3’)
MMP-9 (Hs00957562_m1) (FAM)- GGCGCTCATGTACCCTATGT
GAPDH ( Hs99999905_m1) (FAM)-GGCGCCTGGTCACCAGGGCTGCTTT
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gelatin-8% SDS-PAGE electrophoresis. After electrophor-
esis, the gels were washed with 2.5% Triton X-100 and in-
cubated in a reaction buffer (40 mM Tris–HCl, pH 8.0;
10mM CaCl2 and 0.01% NaN3) at 37°C for 12 h. The gel
was stained with Coomassie brilliant blue R-250 for
visualization.
RNA preparation and TaqMan quantitative real-time PCR
Total RNA was isolated from cancer cells using Trizol
(Life Technologies, Grand Island, NY) according to the
manufacturer’s instructions. Quantitative real-time PCR
analysis was performed using TaqMan one-step PCR
Master Mix (Applied Biosystems). Total cDNA (100 ng)Figure 1 Effect of STE on cell viability and in vitro wound closure in H
150, and 200 μg/mL) for 24 h and 48 h before a MTT assay for cell viability
(B) HONE-1 cells were wounded and then treated with vehicle (DMSO) or
(50 ng/mL) for 0, 12, and 24 h in 0.5% FBS-containing medium. In the diffe
different locations were taken. (C) Cells migrating into the wound area wer
assessment of the mean number of cells in the denuded zone was the me
compared with the TPA treatment group.was added per 25 μl reaction with MMP-9 or GAPDH
primers and TaqMan probes. The MMP-9 and GAPDH
primers and probes were designed using commercial
software (ABI PRISM Sequence Detection System;
Applied Biosystems). The oligonucleotide sequences of
TaqMan probes and primers were described in Table 1.
Quantitative real-time PCR assays were conducted in
triplicate on a StepOnePlus sequence detection system.
Threshold was set above the non-template control back-
ground and within the linear phase of target gene ampli-
fication to calculate the cycle number at which the
transcript was detected [21].
Transfection and MMP-9 promoter-driven luciferase
assays
The HONE-1 cells were seeded at a concentration of
5 x104 cells per well in 6-well cell culture plates. After 24
h of incubation, pGL3-basic (vector) and MMP-9 pro-
moter plasmid were co-transfected with a β-galactosidase
expression vector (pCH110) into cells using Turbofect
(Fermentas, Carlsbad, CA) as previously described [20].ONE-1 cell. (A) HONE-1 cells were treated with STE (0, 25, 50, 75, 100,
. The values are means±SD of at least three independent experiments.
STE (0, 25, 50, 75 and 100 μg/mL) in the presence or absence of TPA
rent time points, phase-contrast pictures of the wounds at three
e counted using the dashed line as time zero. A quantitative
an±SD (n=3). #p<0.05 compared to the vehicle group; *p<0.05
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vehicle or STE (0~50 μg/mL) for 24 h. The cell lysates
were harvested and luciferase activity was determined
using a luciferase assay kit. The value of the luciferase
activity was normalized to transfection efficiency and
monitored by β-galactosidase expression.
Western blot analysis for determining molecular pathway
Total cell lysates or nuclear extracts were prepared as pre-
viously described [22]. The cell lysates were separated in a
10% polyacrylamide gel and transferred onto a nitrocellu-
lose membrane. The blot was subsequently incubated with
5% non-fat milk in Tris-buffered saline (20 mM Tris, 137
mM NaCl, pH 7.6) for 1 h to block non-specific binding,
and then overnight with polyclonal antibodies against
three MAPKs (ERK 1/2, JNK ½, and p38), Src, FAK, and
β-actin with the specific antibodies for unphosphorylated
or phosphorylated forms. The blots were then incubated
with horseradish peroxidase goat anti-rabbit or anti-
mouse IgG for 1 h.Figure 2 Effects of STE on cell migration and invasion in HONE-1 cells
chamber for 16 and 24 h with polycarbonate filters, respectively. The (C) m
counting the number of cells that invaded the underside of the porous po
values represent the means±SD of at least three independent experiments
TPA treatment group.Signal was detected by using an enhanced chemi-
luminescence (ECL) commercial kit (Amersham Biosci-
ences). The relative photographic density was quantitated
by scanning the photographic negatives on a gel docu-
mentation and analysis system (AlphaImager 2000, Alpha
Innotech Corporation, San Leandro, CA, USA).
Statistical analysis
Statistically significant differences were calculated using
the Student’s t-test (Sigma-Stat 2.0, Jandel Scientific, San
Rafael, CA, USA). Significance was set at p<0.05. The
values are the means ± standard deviation (SD) of at
least three independent experiments.
Results
Effect of STE on the viability of HONE-1 cells
The effects of STE on the viability of HONE-1 cells in
24 h and 48 h were assessed by MTT assay and the cyto-
toxic effects of various STE concentrations (0, 25, 50, 75,
100, 150, and 200 μg/mL) were shown in Figure 1A. The. (A) Cell migration and (B) invasion were measured using a Boyden
igration and (D) invasion abilities of HONE-1 cells were quantified by
lycarbonate, as described in the Materials and Methods section. The
. #p<0.05 compared with the vehicle group; *p<0.05 compared to the
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(200 μg/mL), STE altered HONE-1 cell viability. As such,
a lower concentration range of STE (0, 25, 50, 75, and 100
μg/mL) was used for all subsequent experiments.
Inhibitory effects of STE on In vitro wound closure,
migration and invasion of HONE-1 cells
Findings from a wound closure assay determined the ef-
fects of STE on the migration of HONE-1 cells and
contained representative photographs of HONE-1 cells
migrating into the scratch wounds during STE treatment
(Figure 1B). In the wound closure assay, STE significantly
reduced the motility of HONE-1 cells at 24 h (p<0.05)
(Figure 2C).
The migration and invasion assays with the Boyden
chamber were used to investigate effects of STE on
HONE-1 cells. In the well where TPA alone was applied,
there was a 58±3.8% increase in cell migration ability
compared to the control well (p<0.001). Significant re-
ductions (p<0.05) on the migration of HONE-1 cells
were observed when STE concentrations were beyond
25 μg /mL (Figure 2A). In the well where TPA alone was
applied, there was a 52.5±2.3% increase in cell invasion
ability compared to the control well (p<0.001). There
were significant reductions (p<0.05) on the invasion of
HONE-1 cells in all STE concentrations (Figure 2B).Figure 3 Effects of TPA and STE on MMP-9 activity. (A) HONE-1 cells w
cells were treated with TPA (50 ng/mL) for 6, 12, 24 and 48 h. (C-D) HONE-
presence or absence of TPA (50 ng/mL) for 24 h. All of the cells were subje
MMP-2 and MMP-9. The values represented the means±SD of at least three
*p<0.05 compared to the TPA treatment group.Effects of STE on the TPA-induced MMP-9 activity
in HONE-1 cells
Gelatin zymography assay was used to investigate the
enzymatic activity of MMP-2 and MMP-9 on HONE-1
cells following TPA treatment. In the gelatin zymography
assay, TPA significantly increased the MMP-9 activity of
HONE-1 cells in a dose- and time-dependent manner
(p<0.05) (Figure 3A and 3B) while the MMP-2 activity
remained changed. The assay revealed that enzymatic ac-
tivity of MMP-9 could reach up to 1177.7±154.1% of the
control sample after TPA induction (Figure 3C). Except at
low concentrations (25 μg/mL), STE could reduce MMP-9
activity inn HONE-1 cells in a concentration-dependent
manner (Figure 3C and 3D).
Effects of STE on the mRNA expression and promoter
activity of TPA-induced MMP-9 in HONE-1 cells
In the RT-PCR assay, TPA significantly increased the
MMP-9 activity of HONE-1 cells in a time-dependent
manner (p<0.05) (Figure 4A). The inhibitory effects of
various STE concentrations on the mRNA expression of
MMP-9 were investigated using RT-PCR at 6 h after TPA
treatment. Except at low concentrations (25 μg /mL), STE
significantly reduced (p<0.05) MMP-9 mRNA expression
of HONE-1 cells in a concentration-dependent manner
(Figure 4B).ere treated with TPA (1, 5, 10, 50, and 100 ng/mL) for 24 h. (B) HONE-1
1 cells were treated with STE (0, 25, 50, 75, and 100 μg/mL) in the
cted to gelatin zymography analysis to determine the activities of
independent experiments. #p<0.05 compared to the vehicle group;
Figure 4 Effects of STE on mRNA level and MMP-9 promoter activity. (A) HONE-1 cells were treated with TPA (50 ng/mL) for 1, 3, 6, and 24
h and then subjected to RT-PCR to analyze the mRNA levels of MMP-9. (B-C) HONE-1 cells were treated with STE (0, 25, 50, 75, and 100 μg/mL) in
the presence or absence of TPA (50 ng/mL) for 6 h and then subjected to (B) RT-PCR and (C) TaqMan quantitative real-time PCR to analyze the
mRNA levels of MMP-9. (D) HONE-1 cells were treated with STE (0, 25, 50, 75, and 100 μg/mL) in the presence or absence of TPA (50 ng/mL) for
6 h and then subjected to promoter-driven luciferase assays to analyze the promoter activity of MMP-9. The values represented the means±SD of
at least three independent experiments. #p<0.05 compared to the vehicle group; *p<0.05 compared to the TPA treatment group.
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tions on the mRNA expression of MMP-9 in HONE-1
cells, real-time PCR with GAPDH as internal control
was utilized. The treatment of TPA boosted the expres-
sion of MMP-9 mRNA to 428.6±65.4%, while STE sig-
nificantly reduced (p<0.05) the TPA-induced MMP-9
mRNA expression except at the concentrations of
25 μg/mL (Figure 4C). The luciferase activities of
MMP-9 were also significantly suppressed (Figure 4D).
These results suggested that STE regulated MMP-9expression, at least partially, at the transcriptional
level.
Effects of STE on focal adhesion kinase (FAK) activation
The investigation on the molecular regulation of cell mi-
gration indicated the involvement of Src and FAK in
STE treatment. Changes in FAK activation in these cells
were further evaluated using antibodies directed against
the FAK phosphorylation site Tyr925. Western blotting
showed that TPA significantly increased the Src and
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dependent manner (p<0.05) (Figure 5A). Moreover, STE
reduced the phosphorylation of Src and FAK in HONE-1
cells (Figure 5B) (p<0.05), suggesting that STE inhibited
HONE-1 cell migration, at least in part, through the regu-
lation of Src and FAK phosphorylation.
Effects of STE on MAPK pathways
After the inhibitory effects of STE on cell migration/
invasion and proteinases were revealed, the effects of
STE on the expressions of MAPK pathways were in-
vestigated using Western blotting to elucidate their
underlying mechanisms. Western blotting showed that
TPA significantly increased the three MAPK pathway
phosphorylations of HONE-1 cells in a time-dependent
manner (p<0.05) (Figure 6A). Furthermore, STE reduced
the phosphorylation of ErK1/2 in HONE-1 cells, but not
the phosphorylation of the JNK and p38 pathways
(Figures 6B).
To further determine whether STE inhibition of MMP-
9 activity was caused mainly by the inhibition of the ErkFigure 5 Effects of TPA and STE on the phosphorylation level of Src a
30, 60, and 120 min and then subjected to Western blotting to analyze
and 100 μg/mL) in the presence or absence of TPA (50 ng/mL) for 6 h and th
Quantitative results of phosphorylation levels of Src or FAK were adjusted with
of at least three independent experiments. *p<0.05 compared to the vehicle g1/2 signaling pathway, its effects on a specific inhibitor of
the Erk1/2 pathway (U0126) in HONE-1 cells were inves-
tigated. In the gelatin zymography assay, TPA-induced
MMP-9 activity of HONE-1 cells was significantly reduced
by the Erk 1/2 inhibitor (U0126) (Figure 6C). The results
also showed that a combined treatment of the Erk 1/2 in-
hibitor and STE further reduced MMP-9 expression
(Figure 6D). Thus, the inhibition of the Erk 1/2 signaling
pathways might result in reduced MMP-9 expression.
Discussion
The nasopharynx is situated over the base of the skull
where lymphatic tissues and circulation are rich. Metastases
of nasopharyngeal cancer cells to the neck lymph nodes
and distant organs are common in NPC patients, even in
the early stage of the disease. Herbal medicines are a popu-
lar practice of healthcare in eastern countries. Numerous
studies have shown that they are beneficial in the treatment
of many diseases, including cancers [23]. Although the
anti-tumor activities of several herbal medicines against hu-
man NPC cells have been demonstrated previously [24,25],nd FAK. (A) HONE-1 cells were treated with TPA (50 ng/mL) for 15,
Src and FAK levels. (B) HONE-1 cells were treated with STE (0, 50,
en subjected to Western blotting to to analyze Src and FAK levels.
total Src and FAK protein level. The values represented the means±SD
roup; #p<0.05 compared to the TPA treatment group.
Figure 6 Effects of TPA and STE on the MAPK pathway. (A) HONE-1 cells were treated with TPA (50 ng/mL) for 15, 30, 60, and 120 min and
then subjected to Western blotting to analyze the levels of Erk 1/2, JNK, and p38. (B) HONE-1 cells were treated with STE (0, 50, and 100 μg/mL)
in the presence or absence of TPA (50 ng/mL) for 6 h and then subjected to Western blotting to analyze the levels of Erk 1/2, JNK and p38. (C)
HONE-1 cells were pre-treated with U0126 (10 μM), SP600125 (10 μM) and SB203580 (10 μM) for 30 min and then incubated with TPA (50 ng/mL)
for 24 h. The medium was subjected to gelatin zymography as described in the Methods. (D) HONE-1 cells were pre-treated with U0126 (10 or 20 μM)
for 30 min and then incubated in the presence or absence of TPA (50 ng/mL) and STE (50 μg/mL) for 24 h. The medium was subjected to
gelatin zymography. The values represented the means±SD of at least three independent experiments. #p<0.05 compared to the vehicle group;
*p<0.05 compared to the TPA treatment group.
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metastatic activity of herbal medicine for NPC cells. The
present study demonstrates that the extract of Selaginella
tamariscina can significantly inhibit the migration and in-
vasion ability of HONE-1 cancer cells, suggesting a poten-
tial role in the treatment of metastatic NPC.A degradation of the ECM and components of the
basement membrane by MMPs play a crucial role in the
development of cancer metastasis. In vivo evidence from
chicken chorio-allantoic membrane (CAM) assay shows
that MMP-9 is inter-dependent in tumor invasion, while
tumor cells show only low levels of invasion in the absence
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onies are seldom observed in MMP-9-deficient mice
injected intravenously with melanoma or lung carcinoma
cells [27]. Clinically, the positive relationships between
MMP-9 and metastasis in patients with NPC have been
reported [28,29]. The results in the present study demon-
strate that STE inhibits the migration and invasion of hu-
man NPC HONE-1 cells via decreasing the MMP-9
protein levels (Figure 3). To date, this is the first scientific
report related to the inhibitory effect of STE on NPC inva-
siveness via decreased production of tumor metastasis-
related proteins. Since several studies have indicated that
inhibition of MMP expressions or enzyme activities can
be used as early targets for preventing cancer metastasis
[30-32], Selaginella tamariscina may be a potential candi-
date for cancer treatment.
The expression of MMP-9 can be regulated by an in-
flammatory cytokine, a growth factor, or an oncogene
through activation of different intracellular-signaling
pathways [33]. Among these stimulators, TPA is a well-
known substitute for diacylglycerol as a high affinity
ligand for conventional protein kinase C (PKC). It can
induce MMP-9 expression and result in an increase in
invasion in various malignant cell lines [34]. FAK, one of
the major kinases of focal adhesions, is a vital regulator
involved in focal adhesion assembly and cell migration.
FAK becomes activated when it is phosphorylated at
tyrosine 397 (Y397). It is associates with Src and forms a
dual kinase complex [35]. Activated Src phosphorylates
FAK, thereby creating a signaling cascade through the
Ras and mitogen-activated protein kinase (MAPK) [36].
Moreover, the activation of one or more MAPK path-
ways (e.g. ERK1/2, JNK and p38) is known to be import-
ant for the MMP-9 induction by TPA in various cell
types [37-40]. The present study shows that the TPA-
induced MMP-9 expression of HONE-1 cells is accom-
panied by an increase of phosphorylation of Src, FAK,
ERK1/2, JNK and p38. The MAPKs inhibitors test sug-
gests that TPA induces MMP-9 expression through the
ERK1/2 and p38, but not the JNK, pathways. It can be
assumed that the inhibitory effects of STE on TPA-
induced MMP-9 activity of HONE-1 cells may be
through the inactivation of the signaling pathways of
TPA induction. The results here reveal that STE treat-
ment of TPA-induced HONE-1 cells inhibit MMP-9 ex-
pression and ERK1/2 phosphorylation without affecting
JNK and p38 phosphorylation (Figure 6). This indicates
that participation of the Src/FAK/ErK 1/2 pathway is the
putative mechanism for the inhibition of MMP-9 synthe-
sis by STE in human NPC HONE-1 cells.
Several flavonoid compounds have been isolated from
Selaginella tamariscina, including amentoflavone, apigenin,
hinokiflavone, and sotetsuflavone [9,10,41]. Previous studies
have shown that amentoflavone can reduce histaminerelease from rat peritoneal mast cells [42], while apigenin
can inhibits the production of MMPs in various
malignant tumors [43,44]. Oozes et al. report that pro-
inflammatory signals are mediated by TNF-α via path-
ways of nuclear factor-κB (NF-κB) and Akt [45]. Ruiz and
Haller have demonstrated that apigenin inhibits the
pro-inflammatory gene expres- sion in intestinal epithe-
lial cells by blocking Akt phosphorylation/activity [46].
These findings suggest that flavonoids may be the active
compounds responsible for the anti-metastatic activity of
Selaginella tamariscina. Further investigations on the
exact effective components of STE are warranted to
determine its potential use in oncology.
Conclusions
In conclusion, extract of Selaginella tamariscina prevents
the metastasis of HONE-1 cells by the transcriptional in-
hibition of the MMP-9 expression and activity through a
down-regulation of ERK1/2 signaling pathways. These re-
sults suggest that Selaginella tamariscina has the ability to
exert inhibitory effects on critical steps in metastasis, in-
cluding cellular mobility, migration and invasion. How-
ever, the interpretation of this study is limited because the
lack of an in vivo animal study. Selaginella tamariscina
should be further tested by an in vivo model to determine
if it is effective in the prevention of nasopharyngeal carcin-
oma invasion or metastasis.
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